67 results
8-K/A
EX-99.4
CELU
Celularity Inc - Ordinary Shares
16 Aug 21
Completion of Acquisition or Disposition of Assets
5:23pm
and rentals resulting from the sale of the MIST/UltraMIST assets in August 2020, partially offset by (i) an increase of $0.6 million in license, royalty … sold in the product sales and rentals segment driven by the sale of the MIST/UltraMIST assets in August 2020 were offset by higher overall costs due
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
10 Nov 22
Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:19pm
of $6.8 million of previously deferred revenue as a result of the termination of a license agreement partially offset by increased product sales … offset by a reduction in allocated costs.
Selling, General and Administrative
Selling, general and administrative expenses for the three months ended
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
12 Nov 21
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
4:19pm
of $1.4 million, partially offset by a decrease in product sales and rentals revenues of $0.6 million resulting from the sale of the MIST/UltraMIST … , partially offset by a decrease in product sales and rentals revenues of $3.6 million resulting from the sale of the MIST/UltraMIST assets in August
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
10 Aug 22
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
12:00am
was allocated to research and development expense, offset by higher personnel, professional services and, insurance costs to support operations … to our board of directors and senior management, a portion of which was allocated to research and development expense, offset by higher personnel
8-K
EX-99.2
CELU
Celularity Inc - Ordinary Shares
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
as a reduction of the net assets of GX received upon the Business Combination and offset against additional paid-in capital.
Represents additional … costs are recorded as a reduction of the net assets of GX received upon the Business Combination and offset against additional paid-in capital
8-K/A
EX-99.5
q7a8fb9 5n1hh
20 Aug 21
Financial Statements and Exhibits
12:00am
424B3
o8mja1jkwl6n2n0
19 Aug 21
Prospectus supplement
9:22pm
424B3
f9mv78h
12 Nov 21
Prospectus supplement
4:45pm
8-K
EX-99.1
rz3nsmt3shivgyxv
16 Aug 21
Celularity Reports Second Quarter 2021 Financial Results
5:20pm
424B3
u6k1084i 9z
19 Aug 21
Prospectus supplement
9:21pm
S-4
EX-10.32
np8ig5 57a9
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-10.1
sxqssgzysyso6kjev
15 Sep 22
Entry into a Material Definitive Agreement
4:11pm
424B3
gmogpx7unm8c0 3byk
10 Aug 22
Prospectus supplement
12:00am